Skip to main navigation
go to homepage

Parent Menu One

About Us
With Experience and Excellence.
We take your projects to the next level with our personal commitment for your commercial success.

Submenu One

Our Company History Location Leadership Our Approach News Releases

Parent Menu Three

Services & Capabilities
Personally Comitted to Your Success.
Avid Bioservices offers our clients full lifecycle capabilities—from Concept to Commercial Supply. We pride ourselves on the personal commitment our team offers, ensuring your project success, at every step of the way.

Submenu Three

Process Development CGMP Manufacturing Quality and Regulatory Compliance Analytical Services Viral Vector

Parent Menu Four

Facilities
State-of-the-art Infrastructure and Operational Excellence.
Located in Tustin, California, our CGMP facilities are dedicated to mammalian cell culture with production for both clinical and commercial biologics. We provide our clients flexibility by offering stainless steel and single-use options, and work with you to align timelines.

Submenu Four

Our Facilities Expansion

Parent Menu Two

Events
With Presence and Expertise
Our business opera

Submenu Two

Upcoming Events Conferences Webinars Technical Seminars Archived Events Investor Events

Parent Menu Five

Resources
Knowledgeable and Leading the Way.
Our technical team members continue to lead the industry, one process at a time; while expertly providing and sharing resources with our colleagues and industry peers.

Submenu Five

Thought Leadership Archived Webinars Case Studies Presentations Articles Fact Sheets Videos Industry Links Client Resources

Parent Menu Seven

Careers

Parent Menu Six

Investors
Investor Relations
 

Investor Relations

Overview Investor Events News Releases SEC Filings Corporate Governance Stock Quote & Chart Analyst Coverage Investor FAQs Email Alerts Contact Us

Mobile Menu

Our Company Leadership Our Approach News Releases Press Releases
Capabilities & Services Process Development CGMP Manufacturing Quality and Regulatory Compliance Analytical Services
Franklin Facility Myford Facility
Upcoming Events Investor Events
Thought Leadership Fact Sheets Videos Industry Links Client Resources
Careers
Overview Investor Events News Releases SEC Filings Corporate Governance Stock Quote & Chart Analyst Coverage Investors FAQs Email Alerts Contact Us
Contact Us
go to contact page

News Releases

News Releases

Jun 29 2021
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments
Jun 22 2021
Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021
May 25 2021
Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics’ ZYNLONTA™ (Loncastuximab Tesirine-Lpyl)
Apr 15 2021
Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock
Mar 17 2021
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 10 2021
Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes
Mar 8 2021
Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes
Mar 8 2021
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent Developments
Mar 3 2021
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 1 2021
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Footer Menu

About Us Services & Capabilities Facilities Events Resources Careers Investors Contact Us

Social

go to avid bioservices twitter page go to the contact page

Legal

Privacy Policy
Copyright © 2023 Avid Bioservices, Inc. All Rights Reserved